Stock Track | Vericel Surges 8.47% Pre-Market on Strong Q3 Earnings Beat and Positive Outlook

Stock Track11-06

Vericel Corporation (VCEL) stock soared 8.47% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The biotechnology company significantly outperformed market expectations, demonstrating robust growth and improved profitability.

The Q3 earnings report revealed several positive highlights: - Revenue reached $67.503 million, surpassing the IBES estimate of $64.6 million. - Earnings per share (EPS) came in at $0.10, beating the estimated loss of $0.01 per share. - Gross profit stood at $49.585 million, with a strong gross margin of 73.5%. - Adjusted EBITDA was $16.996 million, representing a 25% adjusted EBITDA margin. - Net income for the quarter was $5.074 million.

Adding to the optimistic sentiment, Vericel provided a favorable full-year revenue outlook of $272-276 million, which aligns well with the current IBES estimate of $275.3 million for FY2025. This strong performance and positive guidance suggest that Vericel is executing well on its growth strategy and maintaining a solid position in its market segments, driving investor confidence and the significant pre-market stock price increase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115189969?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 20:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115189969","market":"hk","top_or_hot":-1,"title":"Stock Track | Vericel Surges 8.47% Pre-Market on Strong Q3 Earnings Beat and Positive Outlook","media":"Stock Track","content":"<p>Vericel Corporation (VCEL) stock soared 8.47% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The biotechnology company significantly outperformed market expectations, demonstrating robust growth and improved profitability.</p>\n\n<p>The Q3 earnings report revealed several positive highlights:\n- Revenue reached $67.503 million, surpassing the IBES estimate of $64.6 million.\n- Earnings per share (EPS) came in at $0.10, beating the estimated loss of $0.01 per share.\n- Gross profit stood at $49.585 million, with a strong gross margin of 73.5%.\n- Adjusted EBITDA was $16.996 million, representing a 25% adjusted EBITDA margin.\n- Net income for the quarter was $5.074 million.</p>\n\n<p>Adding to the optimistic sentiment, Vericel provided a favorable full-year revenue outlook of $272-276 million, which aligns well with the current IBES estimate of $275.3 million for FY2025. This strong performance and positive guidance suggest that Vericel is executing well on its growth strategy and maintaining a solid position in its market segments, driving investor confidence and the significant pre-market stock price increase.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Vericel Surges 8.47% Pre-Market on Strong Q3 Earnings Beat and Positive Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Vericel Surges 8.47% Pre-Market on Strong Q3 Earnings Beat and Positive Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-06 20:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vericel Corporation (VCEL) stock soared 8.47% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The biotechnology company significantly outperformed market expectations, demonstrating robust growth and improved profitability.</p>\n\n<p>The Q3 earnings report revealed several positive highlights:\n- Revenue reached $67.503 million, surpassing the IBES estimate of $64.6 million.\n- Earnings per share (EPS) came in at $0.10, beating the estimated loss of $0.01 per share.\n- Gross profit stood at $49.585 million, with a strong gross margin of 73.5%.\n- Adjusted EBITDA was $16.996 million, representing a 25% adjusted EBITDA margin.\n- Net income for the quarter was $5.074 million.</p>\n\n<p>Adding to the optimistic sentiment, Vericel provided a favorable full-year revenue outlook of $272-276 million, which aligns well with the current IBES estimate of $275.3 million for FY2025. This strong performance and positive guidance suggest that Vericel is executing well on its growth strategy and maintaining a solid position in its market segments, driving investor confidence and the significant pre-market stock price increase.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VCEL","symbol_name":"Vericel Corporation","start_time":0,"source_url":"","article_id":"1115189969","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115189969","pubTimestamp":1762433902,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Vericel Corporation (VCEL) stock soared 8.47% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The biotechnology company significantly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VCEL":"Vericel Corporation"},"translate_title":"个股追踪|Vericel盘前大涨8.47%，第三季度盈利强劲，前景乐观","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VCEL":1},"content_text":"Vericel Corporation (VCEL) stock soared 8.47% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The biotechnology company significantly outperformed market expectations, demonstrating robust growth and improved profitability.\nThe Q3 earnings report revealed several positive highlights:\n- Revenue reached $67.503 million, surpassing the IBES estimate of $64.6 million.\n- Earnings per share (EPS) came in at $0.10, beating the estimated loss of $0.01 per share.\n- Gross profit stood at $49.585 million, with a strong gross margin of 73.5%.\n- Adjusted EBITDA was $16.996 million, representing a 25% adjusted EBITDA margin.\n- Net income for the quarter was $5.074 million.\nAdding to the optimistic sentiment, Vericel provided a favorable full-year revenue outlook of $272-276 million, which aligns well with the current IBES estimate of $275.3 million for FY2025. This strong performance and positive guidance suggest that Vericel is executing well on its growth strategy and maintaining a solid position in its market segments, driving investor confidence and the significant pre-market stock price increase.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115189969","isCrawlerRequest":true}